This conserved lipid acyltransferase has many re-entrant segments but only one true TM helix. Most closely related to bacterial acyltransferases.. Heavily expanded in kinetoplastids for unknown reasons. Localization: ER (by homology)
Phospholipid biosynthesis, Acyltransferase-like , copy 1
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 45 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 30 |
NetGPI | no | yes: 0, no: 30 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 23 |
GO:0110165 | cellular anatomical entity | 1 | 23 |
Related structures:
AlphaFold database: A4HSA1
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 4 |
GO:0006644 | phospholipid metabolic process | 4 | 4 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 4 |
GO:0006654 | phosphatidic acid biosynthetic process | 6 | 4 |
GO:0006793 | phosphorus metabolic process | 3 | 4 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 4 |
GO:0008152 | metabolic process | 1 | 4 |
GO:0008610 | lipid biosynthetic process | 4 | 4 |
GO:0008654 | phospholipid biosynthetic process | 5 | 4 |
GO:0009058 | biosynthetic process | 2 | 4 |
GO:0009987 | cellular process | 1 | 4 |
GO:0019637 | organophosphate metabolic process | 3 | 4 |
GO:0044237 | cellular metabolic process | 2 | 4 |
GO:0044238 | primary metabolic process | 2 | 4 |
GO:0044249 | cellular biosynthetic process | 3 | 4 |
GO:0044255 | cellular lipid metabolic process | 3 | 4 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 4 |
GO:0046473 | phosphatidic acid metabolic process | 6 | 4 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 4 |
GO:0046486 | glycerolipid metabolic process | 4 | 4 |
GO:0071704 | organic substance metabolic process | 2 | 4 |
GO:0090407 | organophosphate biosynthetic process | 4 | 4 |
GO:1901576 | organic substance biosynthetic process | 3 | 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 31 |
GO:0016740 | transferase activity | 2 | 31 |
GO:0016746 | acyltransferase activity | 3 | 31 |
GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity | 7 | 6 |
GO:0008374 | O-acyltransferase activity | 5 | 6 |
GO:0016411 | acylglycerol O-acyltransferase activity | 6 | 6 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 6 |
GO:0042171 | lysophosphatidic acid acyltransferase activity | 6 | 6 |
GO:0071617 | lysophospholipid acyltransferase activity | 5 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 296 | 300 | PF00656 | 0.310 |
CLV_MEL_PAP_1 | 156 | 162 | PF00089 | 0.536 |
CLV_NRD_NRD_1 | 147 | 149 | PF00675 | 0.524 |
CLV_NRD_NRD_1 | 278 | 280 | PF00675 | 0.553 |
CLV_PCSK_KEX2_1 | 278 | 280 | PF00082 | 0.555 |
CLV_PCSK_SKI1_1 | 134 | 138 | PF00082 | 0.517 |
DEG_APCC_DBOX_1 | 20 | 28 | PF00400 | 0.431 |
DOC_CYCLIN_RxL_1 | 131 | 141 | PF00134 | 0.325 |
DOC_MAPK_DCC_7 | 21 | 29 | PF00069 | 0.350 |
DOC_MAPK_DCC_7 | 67 | 75 | PF00069 | 0.400 |
DOC_MAPK_gen_1 | 21 | 29 | PF00069 | 0.311 |
DOC_MAPK_MEF2A_6 | 21 | 29 | PF00069 | 0.316 |
DOC_MAPK_MEF2A_6 | 31 | 39 | PF00069 | 0.278 |
DOC_MAPK_MEF2A_6 | 67 | 75 | PF00069 | 0.380 |
DOC_PP1_RVXF_1 | 76 | 83 | PF00149 | 0.346 |
DOC_PP1_RVXF_1 | 99 | 105 | PF00149 | 0.436 |
DOC_PP2B_LxvP_1 | 58 | 61 | PF13499 | 0.572 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.204 |
DOC_WW_Pin1_4 | 128 | 133 | PF00397 | 0.313 |
LIG_14-3-3_CanoR_1 | 101 | 105 | PF00244 | 0.388 |
LIG_APCC_ABBA_1 | 199 | 204 | PF00400 | 0.313 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.472 |
LIG_BRCT_BRCA1_1 | 4 | 8 | PF00533 | 0.457 |
LIG_deltaCOP1_diTrp_1 | 241 | 247 | PF00928 | 0.296 |
LIG_EH1_1 | 33 | 41 | PF00400 | 0.256 |
LIG_FHA_1 | 47 | 53 | PF00498 | 0.331 |
LIG_FHA_1 | 60 | 66 | PF00498 | 0.496 |
LIG_GBD_Chelix_1 | 11 | 19 | PF00786 | 0.375 |
LIG_LIR_Gen_1 | 123 | 133 | PF02991 | 0.285 |
LIG_LIR_Gen_1 | 5 | 15 | PF02991 | 0.431 |
LIG_LIR_LC3C_4 | 49 | 53 | PF02991 | 0.341 |
LIG_LIR_Nem_3 | 103 | 107 | PF02991 | 0.344 |
LIG_LIR_Nem_3 | 120 | 125 | PF02991 | 0.301 |
LIG_LIR_Nem_3 | 131 | 136 | PF02991 | 0.297 |
LIG_LIR_Nem_3 | 231 | 236 | PF02991 | 0.274 |
LIG_LIR_Nem_3 | 5 | 11 | PF02991 | 0.452 |
LIG_Pex14_2 | 153 | 157 | PF04695 | 0.318 |
LIG_Pex14_2 | 163 | 167 | PF04695 | 0.285 |
LIG_Pex14_2 | 222 | 226 | PF04695 | 0.310 |
LIG_Pex14_2 | 77 | 81 | PF04695 | 0.377 |
LIG_SH2_CRK | 125 | 129 | PF00017 | 0.341 |
LIG_SH2_PTP2 | 17 | 20 | PF00017 | 0.243 |
LIG_SH2_STAT3 | 63 | 66 | PF00017 | 0.431 |
LIG_SH2_STAT5 | 114 | 117 | PF00017 | 0.395 |
LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.252 |
LIG_SH2_STAT5 | 17 | 20 | PF00017 | 0.295 |
LIG_SH2_STAT5 | 64 | 67 | PF00017 | 0.537 |
LIG_SH3_3 | 210 | 216 | PF00018 | 0.387 |
LIG_TYR_ITIM | 15 | 20 | PF00017 | 0.377 |
LIG_UBA3_1 | 221 | 227 | PF00899 | 0.291 |
MOD_CDK_SPxK_1 | 128 | 134 | PF00069 | 0.336 |
MOD_CK1_1 | 46 | 52 | PF00069 | 0.375 |
MOD_CMANNOS | 244 | 247 | PF00535 | 0.586 |
MOD_GlcNHglycan | 168 | 171 | PF01048 | 0.588 |
MOD_GlcNHglycan | 194 | 197 | PF01048 | 0.528 |
MOD_GlcNHglycan | 301 | 304 | PF01048 | 0.645 |
MOD_GlcNHglycan | 45 | 48 | PF01048 | 0.341 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.307 |
MOD_GSK3_1 | 270 | 277 | PF00069 | 0.331 |
MOD_NEK2_1 | 136 | 141 | PF00069 | 0.262 |
MOD_NEK2_1 | 142 | 147 | PF00069 | 0.294 |
MOD_PIKK_1 | 105 | 111 | PF00454 | 0.258 |
MOD_PKA_2 | 100 | 106 | PF00069 | 0.359 |
MOD_Plk_1 | 240 | 246 | PF00069 | 0.356 |
MOD_Plk_4 | 117 | 123 | PF00069 | 0.270 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.474 |
MOD_Plk_4 | 221 | 227 | PF00069 | 0.325 |
MOD_Plk_4 | 229 | 235 | PF00069 | 0.336 |
MOD_Plk_4 | 38 | 44 | PF00069 | 0.337 |
MOD_Plk_4 | 59 | 65 | PF00069 | 0.616 |
MOD_ProDKin_1 | 128 | 134 | PF00069 | 0.313 |
MOD_SUMO_rev_2 | 267 | 276 | PF00179 | 0.332 |
MOD_SUMO_rev_2 | 290 | 300 | PF00179 | 0.292 |
MOD_SUMO_rev_2 | 302 | 308 | PF00179 | 0.376 |
TRG_ENDOCYTIC_2 | 125 | 128 | PF00928 | 0.363 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.363 |
TRG_ENDOCYTIC_2 | 219 | 222 | PF00928 | 0.310 |
TRG_ENDOCYTIC_2 | 233 | 236 | PF00928 | 0.279 |
TRG_ENDOCYTIC_2 | 288 | 291 | PF00928 | 0.388 |
TRG_ER_diArg_1 | 20 | 23 | PF00400 | 0.386 |
TRG_ER_diArg_1 | 278 | 280 | PF00400 | 0.375 |
TRG_NES_CRM1_1 | 256 | 269 | PF08389 | 0.299 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P455 | Leptomonas seymouri | 55% | 90% |
A0A0N1HTP4 | Leptomonas seymouri | 66% | 100% |
A0A0N1I6V1 | Leptomonas seymouri | 35% | 100% |
A0A0N1IKX5 | Leptomonas seymouri | 34% | 100% |
A0A0S4IQ05 | Bodo saltans | 31% | 91% |
A0A0S4IR22 | Bodo saltans | 42% | 100% |
A0A0S4JRB2 | Bodo saltans | 31% | 97% |
A0A1X0P9F0 | Trypanosomatidae | 33% | 100% |
A0A3Q8IFY7 | Leishmania donovani | 24% | 100% |
A0A3R7NKA0 | Trypanosoma rangeli | 33% | 100% |
A0A3S5H5E4 | Leishmania donovani | 99% | 71% |
A0A3S5H7L8 | Leishmania donovani | 34% | 95% |
A0A3S7WNW6 | Leishmania donovani | 52% | 87% |
A4H418 | Leishmania braziliensis | 72% | 100% |
A4H419 | Leishmania braziliensis | 65% | 100% |
A4H420 | Leishmania braziliensis | 53% | 100% |
A4HHM7 | Leishmania braziliensis | 32% | 100% |
A4HSA2 | Leishmania infantum | 52% | 87% |
A4I4U1 | Leishmania infantum | 30% | 95% |
A4I4U2 | Leishmania infantum | 34% | 100% |
A4I816 | Leishmania infantum | 24% | 100% |
C9ZLI8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9AE89 | Leishmania major | 31% | 100% |
E9AE90 | Leishmania major | 33% | 100% |
E9AK86 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 51% | 100% |
E9ALJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
Q9NF90 | Leishmania major | 52% | 100% |
Q9NF91 | Leishmania major | 93% | 100% |
V5C201 | Trypanosoma cruzi | 31% | 100% |